Position in MRNA
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$1,729,333
+$1,487,073 QoQ
Shares Held
34,042
+314.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Belpointe Asset Management LLC holds $7,054,376 across 13 Biotechnology names. MRNA ranks #1 (24.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
This page
|
34,042 | $1,729,333 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,213 | $1,709,852 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,776 | $1,239,595 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
15,088 | $975,137 | |
| 5 | SPRY |
ARS Pharmaceuticals, Inc.
|
38,445 | $308,713 | |
| 6 | GALT |
Galectin Therapeutics Inc
|
106,139 | $296,127 | |
| 7 | INCY |
Incyte Corp
|
2,742 | $258,077 | |
| 8 | KLRS |
Kalaris Therapeutics, Inc.
|
40,000 | $230,800 |
All Filings in MRNA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,729,333 | 34,042 | Shares | Other | 2026-04-28 | |
| 2025-12-31 | $242,260 | 8,215 | Shares | Other | 2026-01-27 | |
| 2025-09-30 | $212,012 | 8,208 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $226,458 | 8,208 | Shares | Other | 2025-07-22 | |
| 2025-03-31 | $232,271 | 8,193 | Shares | Other | 2025-05-20 | |
| 2024-09-30 | $462,931 | 6,927 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $244,862 | 2,062 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $1,902,309 | 17,852 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,518,104 | 15,265 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $782,938 | 7,580 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $271,431 | 2,234 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $4,135,448 | 26,927 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,630,009 | 31,344 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,236,107 | 18,910 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $711,678 | 4,982 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $946,051 | 5,492 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,311,552 | 5,164 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,336,869 | 6,072 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,798,066 | 7,652 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $685,392 | 5,234 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $638,416 | 6,111 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $411,552 | 5,817 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $503,663 | 7,844 | Shares | Sole | 2020-07-20 | |
| No filing history on record for this holder in this stock. | ||||||